12th EDRN Scientific Workshop - Tuesday 23 March Agenda

20th Year of EDRN: Making Cancer Detection Possible

Tuesday, March 23, 2021 (9:45 a.m. - 6:10 p.m. Eastern Daylight Time)

9:45 a.m. - 10:00 a.m. EDT	Admittance to Workshop via Zoom/General Announcements
10:00 a.m. - 10:05 a.m. EDT (all times Eastern Daylight Time)	Welcome and Opening of the March 2021 EDRN Scientific Workshop Joshua LaBaer, MD, PhD, Arizona State University/The Biodesign Institute Arul Chinnaiyan, MD, PhD, University of Michigan Sudhir Srivastava, PhD, MPH, National Cancer Institute
10:05 a.m. - 10:15 a.m. EDT	Opening Remarks Ned Sharpless, MD, Director, National Cancer Institute
10:15 a.m. - 10:40 a.m. EDT	Life-Time Experience with Cancer Diagnostics Robert Bast, MD, The University of Texas MD Anderson Cancer Center
10:40 a.m. - 10:45 a.m. EDT	Q&A
10:45 a.m. - 1:15 p.m. EDT	Session 1 - Integrated Approaches to Biomarker Research
10:45 a.m. - 10:50 p.m. EDT	Introduction to the Session Moderators: Denise Aberle, MD, University of California, Los Angeles Hui Zhang, PhD, Johns Hopkins University School of Medicine
10:50 a.m. - 11:10 a.m. EDT	Precision Medicine of Lung Cancer: Metabolome and Microbiome Curt Harris, MD, National Cancer Institute
11:10 a.m. - 11:15 a.m. EDT	Q&A
11:15 a.m. - 11:35 a.m. EDT	TBD Arul Chinnaiyan, MD, PhD, University of Michigan
11:35 a.m. - 11:40 a.m. EDT	Q&A
11:40 a.m. - 11:50 a.m. EDT	Break
11:50 a.m. - 12:10 p.m. EDT	TBD James Herman, MD, University of Pittsburgh School of Medicine
12:10 p.m. - 12:15 p.m. EDT	Q&A
12:15 p.m. - 12:35 p.m. EDT	The Immunogenicity of Post-Translational Protein Modifications Karen Anderson, MD, PhD, Arizona State University/The Biodesign Institute
12:35 p.m. - 12:40 p.m. EDT	Q&A
12:40 p.m. - 1:10 p.m. EDT	TBD Ash Alizadeh, MD, PhD, Stanford Comprehensive Cancer Center
1:10 p.m. - 1:15 p.m. EDT	Q&A
1:15 p.m. - 1:35 p.m. EDT	Break
1:35 p.m. - 3:45 p.m. EDT	Session 2 - Integrated Approaches to Biomarker Research II
1:35 p.m. - 1:40 p.m. EDT	Introduction to the Session Moderators: Surinder Batra, PhD, University of Nebraska Medical Center Zhen Zhang, PhD, Johns Hopkins University
1:40 p.m. - 2:00 p.m. EDT	Decoding the Cancer Mucinome Carolyn Bertozzi, PhD, Stanford School of Humanities and Sciences
2:00 p.m. - 2:05 p.m. EDT	Q&A
2:05 p.m. - 2:25 p.m. EDT	TBD Matthew Schabath, PhD, H. Lee Moffit Cancer Center and Research Institute
2:25 p.m. - 2:30 p.m. EDT	Q&A
2:30 p.m. - 2:50 p.m. EDT	Multi-Disciplinary Strategies for Cancer Early Detection Victoria Seewaldt, MD, City of Hope
2:50 p.m. - 2:55 p.m. EDT	Q&A
2:55 p.m. - 3:15 p.m. EDT	TBD Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center
3:15 p.m. - 3:20 p.m. EDT	Q&A
3:20 p.m. - 3:40 p.m. EDT	A Unique Approach Combining Avatar Mice and Mass Spectrometry to Identify Blood Biomarkers for Early Detection of Breast Cancer Amanda Paulovich, MD, PhD, Fred Hutchinson Cancer Research Center
3:40 p.m. - 3:45 p.m. EDT	Q&A
3:45 p.m. - 4:00 p.m. EDT	Break
4:00 p.m. - 6:10 p.m. EDT	Session 3 - Research Excellence through Alliance of Consortia
4:00 p.m. - 4:05 p.m. EDT	Introduction by Session Moderators Moderator: Barbara Kenner, PhD, Kenner Family Research Fund
4:05 p.m. - 4:25 p.m. EDT	Pancreatic Cancer Detection Consortium Michael Goggins, MD, Johns Hopkins University School of Medicine
4:25 p.m. - 4:30 p.m. EDT	Q&A
4:30 p.m. - 4:50 p.m. EDT	Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer Stephen Pandol, MD, Cedars-Sinai Medical Center
4:50 p.m. - 4:55 p.m. EDT	Q&A
4:55 p.m. - 5:15 p.m. EDT	Translational Liver Consortium Hashem El-Serag, MD, MPH, Baylor College of Medicine
5:15 p.m. - 5:20 p.m. EDT	Q&A
5:20 p.m. - 5:40 p.m. EDT	Exosomes - Rigor and Reproducibility David Lyden, MD, PhD, Weill Cornell Medicine
5:40 p.m. - 5:45 p.m. EDT	Q&A
5:45 p.m. - 6:05 p.m. EDT	Pre-Cancer Atlas Peter Sorger, PhD, Harvard Medical School
6:05 p.m. - 6:10 p.m. EDT	Q&A
6:10 p.m. EDT	Adjourn for the Day